campesterol has been researched along with Hyperlipoproteinemia Type II in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Dateki, S; Ikeda, K; Kashimada, K; Komiya, C; Mishima, H; Nakano, Y; Ogawa, Y; Shiba, K; Shimizu, H; Tsujimoto, K; Yamada, T; Yoshiura, KI | 1 |
| Groen, AK; Hutten, BA; Jakulj, L; Kastelein, JJ; Lutjohann, D; Veltri, EP; Vissers, MN | 1 |
| Arca, M; Averna, M; Barraco, G; Cefalù, AB; Fayer, F; Martino, E; Martino, F; Minà, M; Montali, A; Noto, D | 1 |
| Gylling, H; Ketomaki, A; Miettinen, TA | 1 |
| Amundsen, AL; Ntanios, F; Ose, L; Put, Nv | 1 |
| Antikainen, M; Gylling, H; Hedman, M; Ketomäki, A; Miettinen, TA | 1 |
| Becker, M; Staab, D; Von Bergmann, K | 1 |
| Braesen, JH; Gebhardt, A; Harsch, M; Lang, G; Löser, R; Niendorf, A; Reymann, A; Schliack, M | 1 |
| Miettinen, TA; Vanhanen, H | 1 |
| de Knijff, P; Gevers Leuven, JA; Havekes, L; Kempen, HJ; van der Voort, HA | 1 |
| Koivisto, PV; Miettinen, TA | 1 |
3 trial(s) available for campesterol and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.
Topics: Adult; Aged; Anticholesteremic Agents; Azetidines; Biomarkers; Cholesterol; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Intestinal Absorption; Male; Middle Aged; Phytosterols; Simvastatin; Sitosterols; Statistics as Topic | 2010 |
Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread.
Topics: Adolescent; Adult; Carotenoids; Child; Cholesterol; Cross-Over Studies; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Margarine; Middle Aged; Patient Compliance; Phytosterols; Sitosterols; Treatment Outcome | 2004 |
Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.
Topics: Adolescent; Anticholesteremic Agents; Child; Cholestanol; Cholesterol; Desmosterol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Phytosterols; Pravastatin; Sitosterols; Triglycerides | 2006 |
8 other study(ies) available for campesterol and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
A case of ezetimibe-effective hypercholesterolemia with a novel heterozygous variant in ABCG5.
Topics: Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 5; Cholesterol; Cholesterol, LDL; Diagnostic Errors; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Intestinal Diseases; Lipid Metabolism, Inborn Errors; Lipoproteins; Loss of Function Mutation; Middle Aged; Phytosterols; Sitosterols; Treatment Failure | 2020 |
Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia.
Topics: Adolescent; Biomarkers; Case-Control Studies; Child; Cholesterol; Discriminant Analysis; Female; Gas Chromatography-Mass Spectrometry; Genetic Predisposition to Disease; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Italy; Male; Multifactorial Inheritance; Phytosterols; Predictive Value of Tests; Sitosterols; Sterols | 2010 |
Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject.
Topics: Adult; Blood Component Removal; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dietary Fats; Double-Blind Method; Female; Heterozygote; Homozygote; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Margarine; Middle Aged; Phytosterols; Sitosterols; Squalene; Triglycerides | 2004 |
Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol.
Topics: Adolescent; Alanine Transaminase; Alkaline Phosphatase; Apolipoproteins B; Carotenoids; Child; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Feces; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Phytosterols; Sitosterols; Sterols | 1993 |
Effects of pravastatin on cholesterol metabolism of cholesterol-fed heterozygous WHHL rabbits.
Topics: Animals; Anticholesteremic Agents; Cholesterol; Cholesterol, Dietary; Heterozygote; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Immunohistochemistry; Intestinal Absorption; Liver; Phytosterols; Polymerase Chain Reaction; Pravastatin; Rabbits; Receptors, LDL; RNA, Messenger | 1998 |
Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia.
Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Desmosterol; Female; Humans; Hyperlipoproteinemia Type II; Isomerism; Lovastatin; Male; Middle Aged; Phytosterols; Pravastatin; Sitosterols; Triglycerides | 1992 |
Lathosterol level in plasma is elevated in type III hyperlipoproteinemia, but not in non-type III subjects with apolipoprotein E2/2 phenotype, nor in type IIa or IIb hyperlipoproteinemia.
Topics: Analysis of Variance; Apolipoprotein E2; Apolipoproteins E; Cholesterol; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Isomerism; Phenotype; Phytosterols; Sitosterols | 1991 |
Effect of ileal exclusion on plant sterol metabolism in familial hypercholesterolemia.
Topics: Bile Acids and Salts; Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Ileum; Intestinal Absorption; Jejunoileal Bypass; Male; Middle Aged; Phytosterols; Sitosterols | 1987 |